Company profile: Noctrix Health
1.1 - Company Overview
Company description
- Provider of early-stage medical device development, focusing on creating a revolutionary therapy for a chronic illness.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Noctrix Health
Lundbeck
HQ: Denmark
Website
- Description: Provider of pharmaceuticals for psychiatric and neurological disorders, engaged globally in the research, development, production, marketing, and sale of these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lundbeck company profile →
Autobahn Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage restorative treatments for neuropsychiatric and neuroimmunologic disorders, including ABX-002 (CNS-directed TRβ agonist for major depressive disorder), ABX-003 (next-generation TRβ-selective thyromimetic in IND-enabling studies), ABX-101 (S1P receptor modulator with neuroinflammatory and neuroprotective benefits), and a brain-targeting chemistry platform for tailored CNS/peripheral drug exposure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Autobahn Therapeutics company profile →
Arrivo BioVentures
HQ: United States
Website
- Description: Provider of pharmaceutical development focused on identifying biologics and small molecules to improve patient care, including RABI-767, a small-molecule lipase inhibitor for severe acute pancreatitis aiming to prevent systemic toxicity and organ failure, and SP-624, a novel small molecule in Phase 2 for major depressive disorder that targets neuronal connectivity and function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrivo BioVentures company profile →
CereVasc
HQ: United States
Website
- Description: Provider of endovascular medical devices for treating hydrocephalus, including the eShunt System—an endovascularly implantable cerebrospinal fluid shunt with delivery components designed to treat communicating hydrocephalus without invasive surgery—and a portfolio of follow-on product concepts to improve care for neurovascular diseases, including therapies deliverable across the blood-brain barrier.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CereVasc company profile →
Premier Biotech
HQ: United States
Website
- Description: Provider of drug testing diagnostic devices and laboratory services, including drugs of abuse testing delivering accurate results in under 10 minutes with observed collection to prevent adulteration. Offers the OT-Scan app for capturing and reporting drug screen results with automated test interpretation, secure data transmission, and in-app confirmation testing ordering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Premier Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Noctrix Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Noctrix Health
2.2 - Growth funds investing in similar companies to Noctrix Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Noctrix Health
4.2 - Public trading comparable groups for Noctrix Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →